Compare INGR & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INGR | HSIC |
|---|---|---|
| Founded | 1906 | 1932 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Medical Specialities |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 8.8B |
| IPO Year | 1997 | 1995 |
| Metric | INGR | HSIC |
|---|---|---|
| Price | $110.33 | $76.50 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 14 |
| Target Price | ★ $134.57 | $76.50 |
| AVG Volume (30 Days) | 809.5K | ★ 1.3M |
| Earning Date | 02-03-2026 | 11-04-2025 |
| Dividend Yield | ★ 2.95% | N/A |
| EPS Growth | N/A | ★ 30.70 |
| EPS | ★ 10.01 | 3.17 |
| Revenue | $7,262,000,000.00 | ★ $12,938,000,000.00 |
| Revenue This Year | N/A | $5.35 |
| Revenue Next Year | $1.20 | $3.34 |
| P/E Ratio | ★ $11.09 | $24.48 |
| Revenue Growth | N/A | ★ 3.51 |
| 52 Week Low | $102.31 | $60.56 |
| 52 Week High | $141.78 | $82.49 |
| Indicator | INGR | HSIC |
|---|---|---|
| Relative Strength Index (RSI) | 51.05 | 60.39 |
| Support Level | $109.40 | $76.27 |
| Resistance Level | $113.90 | $78.10 |
| Average True Range (ATR) | 1.76 | 1.32 |
| MACD | 0.42 | -0.05 |
| Stochastic Oscillator | 59.07 | 71.53 |
Ingredion is an ingredients provider for the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company sells specialty ingredients that include starch-based texturizers and natural alternative sweeteners such as stevia. Ingredion also sells commodity ingredients that include sweeteners, such as high-fructose corn syrup, and starches, such as those used for sustainable packaging, as well as plant-based proteins.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.